The Eye of the Storm: COVID-19 Vaccination and the Eye
The COVID-19 pandemic has galvanized the global response towards the development of new vaccines based on novel technologies at an unprecedented pace. Since the widespread implementation of vaccination campaigns, case reports on vaccines' systemic side effects, including ocular manifestations,...
Saved in:
Published in | Ophthalmology and therapy Vol. 11; no. 1; pp. 81 - 100 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cheshire
Springer Healthcare
01.02.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The COVID-19 pandemic has galvanized the global response towards the development of new vaccines based on novel technologies at an unprecedented pace. Since the widespread implementation of vaccination campaigns, case reports on vaccines' systemic side effects, including ocular manifestations, have emerged. Since administered vaccines are generally not able to cause the disease in the recipient, or induce an immune response against the pathogen, we hypothesize that the development of ocular phenomena post-COVID-19 vaccination may occur via an immune response elicited by the vaccine. Of many, the most common ocular adverse events include facial nerve palsy, central venous sinus thrombosis and acute anterior uveitis. These COVID-19 vaccine-induced ocular (CVIO) adverse events could resemble the ocular findings in some of the COVID-19 patients. This review will provide a comprehensive overview of published ocular side effects potentially associated with COVID-19 vaccination and serve as a springboard for further research into CVIO adverse events. |
---|---|
AbstractList | The COVID-19 pandemic has galvanized the global response towards the development of new vaccines based on novel technologies at an unprecedented pace. Since the widespread implementation of vaccination campaigns, case reports on vaccines' systemic side effects, including ocular manifestations, have emerged. Since administered vaccines are generally not able to cause the disease in the recipient, or induce an immune response against the pathogen, we hypothesize that the development of ocular phenomena post-COVID-19 vaccination may occur via an immune response elicited by the vaccine. Of many, the most common ocular adverse events include facial nerve palsy, central venous sinus thrombosis and acute anterior uveitis. These COVID-19 vaccine-induced ocular (CVIO) adverse events could resemble the ocular findings in some of the COVID-19 patients. This review will provide a comprehensive overview of published ocular side effects potentially associated with COVID-19 vaccination and serve as a springboard for further research into CVIO adverse events. The COVID-19 pandemic has galvanized the global response towards the development of new vaccines based on novel technologies at an unprecedented pace. Since the widespread implementation of vaccination campaigns, case reports on vaccines' systemic side effects, including ocular manifestations, have emerged. Since administered vaccines are generally not able to cause the disease in the recipient, or induce an immune response against the pathogen, we hypothesize that the development of ocular phenomena post-COVID-19 vaccination may occur via an immune response elicited by the vaccine. Of many, the most common ocular adverse events include facial nerve palsy, central venous sinus thrombosis and acute anterior uveitis. These COVID-19 vaccine-induced ocular (CVIO) adverse events could resemble the ocular findings in some of the COVID-19 patients. This review will provide a comprehensive overview of published ocular side effects potentially associated with COVID-19 vaccination and serve as a springboard for further research into CVIO adverse events.The COVID-19 pandemic has galvanized the global response towards the development of new vaccines based on novel technologies at an unprecedented pace. Since the widespread implementation of vaccination campaigns, case reports on vaccines' systemic side effects, including ocular manifestations, have emerged. Since administered vaccines are generally not able to cause the disease in the recipient, or induce an immune response against the pathogen, we hypothesize that the development of ocular phenomena post-COVID-19 vaccination may occur via an immune response elicited by the vaccine. Of many, the most common ocular adverse events include facial nerve palsy, central venous sinus thrombosis and acute anterior uveitis. These COVID-19 vaccine-induced ocular (CVIO) adverse events could resemble the ocular findings in some of the COVID-19 patients. This review will provide a comprehensive overview of published ocular side effects potentially associated with COVID-19 vaccination and serve as a springboard for further research into CVIO adverse events. |
Author | Ng, Sean Ng, Xin Le Rajamani, Lakshminarayanan Pavesio, Carlos E. Agrawal, Rupesh Gupta, Vishali Betzler, Bjorn Kaijun Rousselot, Andres de Smet, Marc D. Chee, Soon Phaik Singhal, Amit |
Author_xml | – sequence: 1 givenname: Xin Le surname: Ng fullname: Ng, Xin Le organization: National Healthcare Group Eye Institute, Tan Tock Seng Hospital – sequence: 2 givenname: Bjorn Kaijun surname: Betzler fullname: Betzler, Bjorn Kaijun organization: Yong Loo Lin School of Medicine, National University of Singapore – sequence: 3 givenname: Sean surname: Ng fullname: Ng, Sean organization: Lee Kong Chian School of Medicine – sequence: 4 givenname: Soon Phaik surname: Chee fullname: Chee, Soon Phaik organization: Singapore National Eye Centre, Singapore Eye Research Institute, Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Department of Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School – sequence: 5 givenname: Lakshminarayanan surname: Rajamani fullname: Rajamani, Lakshminarayanan organization: Singapore Eye Research Institute, Department of Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School – sequence: 6 givenname: Amit surname: Singhal fullname: Singhal, Amit organization: ASTAR ID Labs & Singapore Immunology Network (SIgN) – sequence: 7 givenname: Andres surname: Rousselot fullname: Rousselot, Andres organization: Department of Ophthalmology, Universidad del Salvador – sequence: 8 givenname: Carlos E. surname: Pavesio fullname: Pavesio, Carlos E. organization: Moorfields Eye Hospital, NHS Foundation Trust – sequence: 9 givenname: Vishali surname: Gupta fullname: Gupta, Vishali organization: Department of Ophthalmology, Advance Eye Centre, Post Graduate Institute of Medical Education and Research – sequence: 10 givenname: Marc D. surname: de Smet fullname: de Smet, Marc D. organization: MicroInvasive Ocular Surgery Clinic, Department of Ophthalmology, University of Leiden – sequence: 11 givenname: Rupesh orcidid: 0000-0002-6662-5850 surname: Agrawal fullname: Agrawal, Rupesh email: rupesh_agrawal@ttsh.com.sg organization: National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Yong Loo Lin School of Medicine, National University of Singapore, Lee Kong Chian School of Medicine, Singapore Eye Research Institute, Department of Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Moorfields Eye Hospital, NHS Foundation Trust |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34914035$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1OAjEUhRuDEURewIWZpZvRttNOWxcmBlFJSFiIbJuZTgeGDC22gwlvb_mRqAtWvUm_c-7NOZegZazRAFwjeIcgZPeeQISTGGIUQ0gQjekZ6GAkkjilmLcOM8eEtkHP-wWEgedUEHIB2gkRiMCEdkA6metosNGRLaMmjO-NdcuHqD-eDp9jJKJpplRlsqayJspMsWMCfgXOy6z2und4u-DjZTDpv8Wj8euw_zSKFWWiiQlKSMkwTikvmRIJZ5wrzgXKc61KyjjTOcJ5qnCBCwpzUUCsKCqDqkAFVEkXPO59V-t8qQulTeOyWq5ctczcRtqskn9_TDWXM_slecooFiIY3B4MnP1ca9_IZeWVruvMaLv2EqcICigw4wG9-b3ruOQnrADgPaCc9d7p8oggKLelyH0pMpQid6XIrYj_E6mq2eUZ7q3q09JkL_Vhj5lpJxd27UzI-5TqG5yFnY0 |
CitedBy_id | crossref_primary_10_1136_bcr_2021_248441 crossref_primary_10_3346_jkms_2023_38_e95 crossref_primary_10_1007_s10792_023_02747_6 crossref_primary_10_7759_cureus_55369 crossref_primary_10_1016_j_xops_2023_100354 crossref_primary_10_18502_jovr_v18i1_12731 crossref_primary_10_1016_j_xops_2024_100474 crossref_primary_10_1210_clinem_dgac606 crossref_primary_10_4103_joco_joco_224_23 crossref_primary_10_1007_s10384_022_00962_9 crossref_primary_10_1159_000529668 crossref_primary_10_1038_s41433_023_02656_z crossref_primary_10_3389_fmicb_2024_1389139 crossref_primary_10_1016_j_survophthal_2024_03_003 crossref_primary_10_1016_j_ophtha_2023_07_017 crossref_primary_10_1167_iovs_64_13_15 crossref_primary_10_3390_vaccines10020342 crossref_primary_10_1007_s00417_022_05954_6 crossref_primary_10_3341_jkos_2022_63_12_1033 crossref_primary_10_1016_j_ajo_2023_09_015 crossref_primary_10_2147_IMCRJ_S398502 crossref_primary_10_2147_OPTH_S460224 crossref_primary_10_12968_opti_2023_267_6898_21 crossref_primary_10_1097_MD9_0000000000000318 crossref_primary_10_3389_fpubh_2022_1051378 crossref_primary_10_1080_09273948_2022_2093757 crossref_primary_10_1186_s12348_022_00311_4 crossref_primary_10_1016_j_jpeds_2023_113682 crossref_primary_10_1080_09273948_2023_2296035 crossref_primary_10_3390_jcm11123318 crossref_primary_10_3390_vaccines10101680 crossref_primary_10_3341_jkos_2024_65_7_465 crossref_primary_10_3390_vaccines11020365 crossref_primary_10_3390_vaccines10030482 crossref_primary_10_1016_j_jfo_2024_104265 crossref_primary_10_1097_ICU_0000000000000855 crossref_primary_10_3389_fmed_2023_1242225 crossref_primary_10_4103_ijo_IJO_1089_22 crossref_primary_10_1016_j_ajo_2024_08_015 crossref_primary_10_3389_fopht_2023_1354084 crossref_primary_10_1016_j_pdpdt_2023_103275 crossref_primary_10_1080_09273948_2022_2058964 crossref_primary_10_4103_IJO_IJO_30_23 crossref_primary_10_1155_crrh_6614757 crossref_primary_10_1016_j_survophthal_2022_09_003 crossref_primary_10_4103_meajo_meajo_61_23 crossref_primary_10_1080_09273948_2022_2125763 crossref_primary_10_1080_09273948_2023_2182324 crossref_primary_10_5005_jp_journals_10078_1408 crossref_primary_10_2147_IMCRJ_S408306 |
Cites_doi | 10.1080/01676830.2020.1867193 10.1080/09273948.2021.1957123 10.1016/j.jaapos.2021.05.003 10.1080/09273948.2021.1949478 10.1038/s41433-021-01671-2 10.1007/s10792-021-01971-2 10.1001/jamaophthalmol.2021.3477 10.1080/02713683.2021.1905001 10.1080/09273948.2021.1974492 10.21203/rs.3.rs-632137/v1 10.1089/thy.2021.0142 10.1080/09273948.2021.1962917 10.1038/s41433-021-01610-1 10.1080/09273948.2021.1961815 10.1007/s00011-021-01476-9 10.2147/IMCRJ.S260252 10.1038/s41577-021-00526-x 10.1016/j.kint.2021.04.025 10.4103/ijo.IJO_1028_21 10.1016/j.ajoc.2020.100917 10.1111/aos.14484 10.12659/MSM.905183 10.1177/0049475519872370 10.1097/ICO.0000000000002761 10.1016/j.vaccine.2004.02.044 10.15585/mmwr.mm7027e2 10.1016/S0140-6736(03)14802-7 10.1080/21645515.2015.1009337 10.1016/j.jneuroim.2014.05.002 10.3390/vaccines9050435 10.1080/09273948.2020.1738501 10.1172/JCI200114235 10.1001/jamaoto.2021.1259 10.1016/j.idcr.2020.e00774 10.1016/S1473-3099(21)00076-1 10.1006/viro.1996.0442 10.1080/09273948.2019.1626188 10.1002/art.30576 10.1001/jamaophthalmol.2020.1291 10.1097/00002281-200001000-00009 10.1093/cid/ciw224 10.1016/j.jneuroim.2007.09.032 10.1016/j.eclinm.2020.100550 10.1038/d41586-020-03626-1 10.1097/WNO.0000000000001049 10.4103/ijo.IJO_1658_21 10.1002/sctm.20-0543 10.1084/jem.20161596 10.1016/j.ajoc.2021.101136 10.1002/jmv.26229 10.1001/jama.2021.7517 10.1016/j.ophtha.2009.05.021 10.1097/WNO.0000000000001146 10.1016/j.ajoc.2021.101200 10.1186/s12348-021-00251-5 10.1177/2324709620976018 10.12659/AJCR.925897 10.1007/BF01204599 10.1038/s41591-020-0968-3 10.1590/0004-282x20200052 10.7326/L20-0845 10.1136/bjophthalmol-2021-319338 10.1128/CMR.19.1.80-94.2006 10.1080/09273948.2020.1792512 10.1016/S0140-6736(21)00872-2 10.1007/s40123-021-00338-1 10.1097/IOP.0000000000001517 10.1016/j.beem.2020.101412 10.1080/24725625.2021.1893961 10.1186/s13054-021-03572-y 10.1080/02713683.2019.1705491 |
ContentType | Journal Article |
Copyright | The Author(s) 2021 2021. The Author(s). |
Copyright_xml | – notice: The Author(s) 2021 – notice: 2021. The Author(s). |
DBID | C6C AAYXX CITATION NPM 7X8 5PM |
DOI | 10.1007/s40123-021-00415-5 |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2193-6528 |
EndPage | 100 |
ExternalDocumentID | PMC8675299 34914035 10_1007_s40123_021_00415_5 |
Genre | Journal Article Review |
GroupedDBID | -A0 0R~ 2VQ 3V. 4.4 53G 7RV 7X7 8AO 8FI 8FJ AAKKN ABDBF ABEEZ ABUWG ACACY ACGFS ACMJI ACUHS ACULB ADBBV ADINQ ADRAZ AFGXO AFKRA AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BKEYQ BPHCQ BVXVI C24 C6C CCPQU DIK EBS EJD FYUFA GROUPED_DOAJ GX1 HMCUK HYE HZ~ IAO IHR ITC KQ8 LGEZI LOTEE M48 M~E NADUK NAPCQ NXXTH O9- OK1 PIMPY PQQKQ PROAC RPM RSV SISQX SMD SOJ UKHRP ~JE AAYXX CITATION PHGZM PHGZT NPM PPXIY 7X8 5PM |
ID | FETCH-LOGICAL-c579t-4134f722658f7c938788c8891bbecf5787eb12b6c2d2d50b9d02c51f34fd1d0c3 |
IEDL.DBID | M48 |
ISSN | 2193-8245 |
IngestDate | Thu Aug 21 13:50:41 EDT 2025 Thu Jul 10 23:07:24 EDT 2025 Mon Jul 21 06:06:01 EDT 2025 Tue Jul 01 01:00:25 EDT 2025 Thu Apr 24 23:11:47 EDT 2025 Fri Feb 21 02:46:34 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | COVID-19 Ocular manifestation Side effects Adverse events Vaccination Uveitis Vaccine |
Language | English |
License | 2021. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c579t-4134f722658f7c938788c8891bbecf5787eb12b6c2d2d50b9d02c51f34fd1d0c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-6662-5850 |
OpenAccessLink | https://link.springer.com/10.1007/s40123-021-00415-5 |
PMID | 34914035 |
PQID | 2610909278 |
PQPubID | 23479 |
PageCount | 20 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8675299 proquest_miscellaneous_2610909278 pubmed_primary_34914035 crossref_primary_10_1007_s40123_021_00415_5 crossref_citationtrail_10_1007_s40123_021_00415_5 springer_journals_10_1007_s40123_021_00415_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-02-01 |
PublicationDateYYYYMMDD | 2022-02-01 |
PublicationDate_xml | – month: 02 year: 2022 text: 2022-02-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Cheshire |
PublicationPlace_xml | – name: Cheshire – name: England |
PublicationTitle | Ophthalmology and therapy |
PublicationTitleAbbrev | Ophthalmol Ther |
PublicationTitleAlternate | Ophthalmol Ther |
PublicationYear | 2022 |
Publisher | Springer Healthcare |
Publisher_xml | – name: Springer Healthcare |
References | Sanjay, Mutalik, Gowda, Mahendradas, Kawali, Shetty (CR35) 2021 Rallis, Ting, Said, Dua (CR50) 2021 Fujinami, von Herrath, Christen, Whitton (CR70) 2006; 19 Seah, Agrawal (CR1) 2020; 28 Bøhler, Strøm, Sandvig, Moe, Jørstad (CR45) 2021 Ball (CR31) 2021; 589 Otaif, Al Somali, Al Habash (CR8) 2020; 20 Martínez Díaz, Copete Piqueras, Blanco Marchite, Vahdani (CR17) 2021 Ravichandran, Natarajan (CR49) 2021; 69 Chau, Chow, Sridhar, Shih (CR20) 2021; 10 Yahalomi, Pikkel, Arnon, Pessach (CR68) 2020; 20 Wu, Duan, Luo, Liu, Qu, Liang (CR18) 2020; 138 Valenzuela, Groth, Taubenslag, Gangaputra (CR46) 2021; 24 Restivo, Centonze, Alesina, Marchese-Ragona (CR19) 2020; 173 Garip, Diedrichs-Möhring, Thurau, Deeg, Wildner (CR62) 2009; 116 Cunningham, Moorthy, Fraunfelder, Zierhut (CR61) 2019; 27 Armstrong, Collin, Mostafa, Queen, Figueiredo, Lako (CR6) 2021; 10 Wasser, Roditi, Zadok, Berkowitz, Weill (CR48) 2021; 40 Greer, Bhatt, Oliveira, Dinkin (CR16) 2020; 40 Zhou, Jones-Lopez, Soneji, Azevedo, Patel (CR13) 2020; 40 Papasavvas, Herbort (CR40) 2021; 11 Scalinci, Trovato (CR7) 2020; 20 Vera-Lastra, Ordinola Navarro, Cruz Domiguez, Medina, Sánchez Valadez, Jara (CR59) 2021 Shemer, Pras, Einan-Lifshitz, Dubinsky-Pertzov, Hecht (CR37) 2021; 147 Rodero, Crow (CR30) 2016; 213 Michel, Stolowy, Gascon, Dupessey, Comet, Attia (CR43) 2021 Mambretti, Huemer, Torregrossa, Ullrich, Findl, Casalino (CR44) 2019; 2021 Mudie, Zick, Dacey, Palestine (CR53) 2021 Leber, Sant’Ana, da Konichi, Raio, Mazzeo, Endo (CR58) 2021 Wraith, Goldman, Lambert (CR27) 2003; 362 Castelli, Pognani, Sozzi, Franchini, Vivona (CR75) 2021; 25 van de Geijn, Tukkie, van Philips, Punt (CR24) 1994; 86 Fuchsjäger-Mayrl, Nepp, Schneeberger, Sator, Dietrich, Wedrich (CR65) 2002; 43 Ferri, Zignego (CR72) 2000; 12 Goyal, Murthy, Annum (CR57) 2021 Detrick, Lee, Chin, Hooper, Chan, Hooks (CR2) 2008; 193 Mazzotta, Giancipoli (CR10) 2020; 13 Fowler, Mendez Martinez, Pallares, Maldonado (CR55) 2021; 23 Basilious, Jivraj, DeAngelis (CR25) 2020; 36 Baxter, Lewis, Fireman, DeStefano, Gee, Klein (CR21) 2016; 63 Invernizzi, Torre, Parrulli, Zicarelli, Schiuma, Colombo (CR11) 2020; 27 Del Bello, Marion, Delas, Congy-Jolivet, Colombat, Kamar (CR33) 2021; 100 Santovito, Pinna (CR52) 2021 Sawalha, Adeodokun, Kamoga (CR12) 2020; 8 Koong, Chee, Toh, Ng, Agrawal, Ho (CR41) 2021 Wucherpfennig (CR71) 2001; 108 Chin, Hooper, Hooks, Detrick (CR4) 2014; 272 Teijaro, Farber (CR29) 2021; 21 Benito-Pascual, Gegúndez, Díaz-Valle, Arriola-Villalobos, Carreño, Culebras (CR67) 2020; 28 Aleem, Nadeem (CR34) 2021 Madendag, Acmaz, Atas, Sahin, Tayyar, Madendag (CR64) 2017; 23 Komurasaki, Nagineni, Wang, Hooks (CR3) 1996; 222 Gargano, Wallace, Hadler, Langley, Su, Oster (CR32) 2021; 70 Mathian, Devilliers, Krivine, Costedoat-Chalumeau, Haroche, Huong (CR73) 2011; 63 ElSheikh, Haseeb, Eleiwa, Elhusseiny (CR42) 2021 Oliveira, Santos, Olivetti, Takahashi (CR15) 2020; 78 Watad, De Marco, Mahajna, Druyan, Eltity, Hijazi (CR28) 2021; 9 Agarwal, Garg, Goyal, Pandit, Srivastava, Srivastava (CR22) 2020; 50 Reyes-Capo, Stevens, Cavuoto (CR54) 2021 Bragazzi, Hejly, Watad, Adawi, Amital, Shoenfeld (CR60) 2020; 34 Méndez Mangana, Barraquer Kargacin, Barraquer (CR9) 2020; 98 Gupta, Madhavan, Sehgal, Nair, Mahajan, Sehrawat (CR5) 2020; 26 Arshi, Sadeghi-Bazargani, Ojaghi, Savadi-Oskouei, Hekmat, Jastan (CR23) 2004; 22 Ozonoff, Nanishi, Levy (CR36) 2021; 21 Bayas, Menacher, Christ, Behrens, Rank, Naumann (CR39) 2021; 397 Bialasiewicz, Farah-Diab, Mebarki (CR56) 2021 Phylactou, Li, Larkin (CR47) 2021; 105 See, Su, Lale, Woo, Guh, Shimabukuro (CR74) 2021; 325 Belghmaidi, Nassih, Boutgayout, El Fakiri, El Qadiry, Hajji (CR14) 2020; 21 Ish, Ish (CR38) 2021; 69 Pichi, Aljneibi, Neri, Hay, Dackiw, Ghazi (CR51) 2021 Su, Chen, Xiong, Bai (CR63) 2020; 45 Bettach, Zadok, Weill, Brosh, Hanhart (CR66) 2021; 93 Chin, Gan, Holder, Tien, Agrawal, Manghani (CR69) 2021; 5 Liang, Meng, Pan, Ye (CR26) 2015; 11 EJ van de Geijn (415_CR24) 1994; 86 JR Teijaro (415_CR29) 2021; 21 I Seah (415_CR1) 2020; 28 T Yahalomi (415_CR68) 2020; 20 KW Wucherpfennig (415_CR71) 2001; 108 A Mathian (415_CR73) 2011; 63 C Mazzotta (415_CR10) 2020; 13 S Zhou (415_CR13) 2020; 40 S Ish (415_CR38) 2021; 69 C Ferri (415_CR72) 2000; 12 MP Rodero (415_CR30) 2016; 213 A Aleem (415_CR34) 2021 RS Fujinami (415_CR70) 2006; 19 L Armstrong (415_CR6) 2021; 10 DP Reyes-Capo (415_CR54) 2021 SZ Scalinci (415_CR7) 2020; 20 K Sawalha (415_CR12) 2020; 8 Y Madendag (415_CR64) 2017; 23 C Méndez Mangana (415_CR9) 2020; 98 A Watad (415_CR28) 2021; 9 E Bettach (415_CR66) 2021; 93 S Ravichandran (415_CR49) 2021; 69 A Gupta (415_CR5) 2020; 26 A Shemer (415_CR37) 2021; 147 DA Restivo (415_CR19) 2020; 173 Y Komurasaki (415_CR3) 1996; 222 P Ball (415_CR31) 2021; 589 A Del Bello (415_CR33) 2021; 100 LI Mudie (415_CR53) 2021 M Goyal (415_CR57) 2021 W Otaif (415_CR8) 2020; 20 B Benito-Pascual (415_CR67) 2020; 28 S Belghmaidi (415_CR14) 2020; 21 KI Rallis (415_CR50) 2021 DA Valenzuela (415_CR46) 2021; 24 F Pichi (415_CR51) 2021 YR Su (415_CR63) 2020; 45 CE Greer (415_CR16) 2020; 40 JW Gargano (415_CR32) 2021; 70 R Baxter (415_CR21) 2016; 63 HM Leber (415_CR58) 2021 GP Castelli (415_CR75) 2021; 25 A Bayas (415_CR39) 2021; 397 P Wu (415_CR18) 2020; 138 RH ElSheikh (415_CR42) 2021 AD Bøhler (415_CR45) 2021 LR Koong (415_CR41) 2021 AA Bialasiewicz (415_CR56) 2021 CYC Chau (415_CR20) 2021; 10 G Fuchsjäger-Mayrl (415_CR65) 2002; 43 LM Wasser (415_CR48) 2021; 40 M Martínez Díaz (415_CR17) 2021 O Vera-Lastra (415_CR59) 2021 MS Chin (415_CR4) 2014; 272 D Chin (415_CR69) 2021; 5 A Basilious (415_CR25) 2020; 36 DC Wraith (415_CR27) 2003; 362 A Agarwal (415_CR22) 2020; 50 N Fowler (415_CR55) 2021; 23 A Garip (415_CR62) 2009; 116 M Phylactou (415_CR47) 2021; 105 M Mambretti (415_CR44) 2019; 2021 T Michel (415_CR43) 2021 A Ozonoff (415_CR36) 2021; 21 RMC Oliveira (415_CR15) 2020; 78 ET Cunningham Jr (415_CR61) 2019; 27 S Arshi (415_CR23) 2004; 22 S Sanjay (415_CR35) 2021 LS Santovito (415_CR52) 2021 A Invernizzi (415_CR11) 2020; 27 I See (415_CR74) 2021; 325 NL Bragazzi (415_CR60) 2020; 34 I Papasavvas (415_CR40) 2021; 11 Y Liang (415_CR26) 2015; 11 B Detrick (415_CR2) 2008; 193 |
References_xml | – year: 2021 ident: CR17 article-title: Acute dacryoadenitis in a patient with SARS-CoV-2 infection publication-title: Orbit doi: 10.1080/01676830.2020.1867193 – year: 2021 ident: CR57 article-title: Bilateral multifocal choroiditis following COVID-19 vaccination publication-title: Ocul Immunol Inflamm doi: 10.1080/09273948.2021.1957123 – volume: 23 start-page: 5657 year: 2017 end-page: 5661 ident: CR64 article-title: The effect of oral contraceptive pills on the macula, the retinal nerve fiber layer, and choroidal thickness publication-title: Med Sci Monit – volume: 40 start-page: 520 year: 2020 end-page: 522 ident: CR16 article-title: Isolated cranial nerve 6 palsy in 6 patients with COVID-19 infection publication-title: J Neuroophthalmol – volume: 69 start-page: 1953 year: 2021 end-page: 1954 ident: CR49 article-title: Corneal graft rejection after COVID-19 vaccination publication-title: Indian J Ophthalmol – volume: 50 start-page: 85 year: 2020 end-page: 86 ident: CR22 article-title: Optic neuritis following anti-rabies vaccine publication-title: Trop Doct – volume: 21 start-page: 195 year: 2021 end-page: 197 ident: CR29 article-title: COVID-19 vaccines: modes of immune activation and future challenges publication-title: Nat Rev Immunol – volume: 397 start-page: e11 year: 2021 ident: CR39 article-title: Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination publication-title: Lancet – volume: 23 start-page: 101136 year: 2021 ident: CR55 article-title: Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine publication-title: Am J Ophthalmol Case Rep – volume: 11 start-page: 2274 year: 2015 end-page: 2280 ident: CR26 article-title: A literature review on the patients with autoimmune diseases following vaccination against infections publication-title: Hum Vaccin Immunother – volume: 5 start-page: 265 year: 2021 end-page: 271 ident: CR69 article-title: Severe retinal vasculitis in systemic lupus erythematosus leading to vision threatening paracentral acute middle maculopathy publication-title: Mod Rheumatol Case Rep – volume: 40 start-page: 1070 year: 2021 end-page: 1072 ident: CR48 article-title: Keratoplasty Rejection After the BNT162b2 messenger RNA Vaccine publication-title: Cornea – volume: 40 start-page: 398 year: 2020 end-page: 402 ident: CR13 article-title: Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and myelitis in COVID-19 publication-title: J Neuroophthalmol – volume: 43 start-page: 2841 year: 2002 end-page: 2844 ident: CR65 article-title: Identification of estrogen and progesterone receptor mRNA expression in the conjunctiva of premenopausal women publication-title: Invest Ophthalmol Vis Sci – volume: 193 start-page: 28 year: 2008 end-page: 37 ident: CR2 article-title: Experimental coronavirus retinopathy (ECOR): retinal degeneration susceptible mice have an augmented interferon and chemokine (CXCL9, CXCL10) response early after virus infection publication-title: J Neuroimmunol – volume: 12 start-page: 53 year: 2000 end-page: 60 ident: CR72 article-title: Relation between infection and autoimmunity in mixed cryoglobulinemia publication-title: Curr Opin Rheumatol – volume: 63 start-page: 79 year: 2016 end-page: 81 ident: CR21 article-title: Case-centered Analysis of optic neuritis after vaccines publication-title: Clin Infect Dis – volume: 45 start-page: 774 year: 2020 end-page: 781 ident: CR63 article-title: Endogenous toll-like receptor 2 modulates Th1/Treg-Promoting Dendritic Cells In Mice Corneal Transplantation Model publication-title: Curr Eye Res – volume: 69 start-page: 2550 year: 2021 end-page: 2552 ident: CR38 article-title: Facial nerve palsy after COVID-19 vaccination: a rare association or a coincidence publication-title: Indian J Ophthalmol – volume: 13 start-page: 513 year: 2020 end-page: 520 ident: CR10 article-title: Anterior acute uveitis report in a SARS-CoV-2 patient managed with adjunctive topical antiseptic prophylaxis Preventing 2019-nCoV spread through the ocular surface route publication-title: Int Med Case Rep J – volume: 21 year: 2020 ident: CR14 article-title: Third cranial nerve palsy presenting with unilateral diplopia and strabismus in a 24-year-old woman with COVID-19 publication-title: Am J Case Rep – volume: 21 start-page: 450 year: 2021 end-page: 452 ident: CR36 article-title: Bell's palsy and SARS-CoV-2 vaccines publication-title: Lancet Infect Dis – volume: 34 start-page: 101412 year: 2020 ident: CR60 article-title: ASIA syndrome and endocrine autoimmune disorders publication-title: Best Pract Res Clin Endocrinol Metab – volume: 2021 start-page: 1 year: 2019 end-page: 4 ident: CR44 article-title: Acute macular neuroretinopathy following coronavirus disease 2019 vaccination publication-title: Ocul Immunol Inflamm – year: 2021 ident: CR54 article-title: Acute abducens nerve palsy following COVID-19 vaccination publication-title: J Am Assoc Pediatr Ophthalmol Strabismus doi: 10.1016/j.jaapos.2021.05.003 – volume: 36 start-page: e16 year: 2020 end-page: e17 ident: CR25 article-title: Acute unilateral ptosis and myositis following the H1N1 influenza vaccine publication-title: Ophthalmic Plast Reconstr Surg – volume: 20 year: 2020 ident: CR7 article-title: Conjunctivitis can be the only presenting sign and symptom of COVID-19 publication-title: IDCases – volume: 272 start-page: 42 year: 2014 end-page: 50 ident: CR4 article-title: Identification of α-fodrin as an autoantigen in experimental coronavirus retinopathy (ECOR) publication-title: J Neuroimmunol – volume: 362 start-page: 1659 year: 2003 end-page: 1666 ident: CR27 article-title: Vaccination and autoimmune disease: what is the evidence? publication-title: Lancet – volume: 70 start-page: 977 year: 2021 end-page: 982 ident: CR32 article-title: Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices-United States, June 2021 publication-title: MMWR Morb Mortal Wkly Rep – volume: 28 start-page: 391 year: 2020 end-page: 395 ident: CR1 article-title: Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals publication-title: Ocul Immunol Inflamm – volume: 98 start-page: e1056 year: 2020 end-page: e1057 ident: CR9 article-title: Episcleritis as an ocular manifestation in a patient with COVID-19 publication-title: Acta Ophthalmol – volume: 9 start-page: 435 year: 2021 ident: CR28 article-title: Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination publication-title: Vaccines (Basel) – volume: 11 start-page: 21 year: 2021 ident: CR40 article-title: Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination publication-title: J Ophthalmic Inflamm Infect – year: 2021 ident: CR53 article-title: Panuveitis following Vaccination for COVID-19 publication-title: Ocul Immunol Inflamm doi: 10.1080/09273948.2021.1949478 – year: 2021 ident: CR50 article-title: Corneal graft rejection following COVID-19 vaccine publication-title: Eye (London) doi: 10.1038/s41433-021-01671-2 – volume: 100 start-page: 238 year: 2021 end-page: 239 ident: CR33 article-title: Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a patient who underwent a kidney transplant publication-title: Kidney Int – volume: 24 start-page: 101200 year: 2021 ident: CR46 article-title: Acute macular neuroretinopathy following Pfizer-BioNTech COVID-19 vaccination publication-title: Am J Ophthalmol Case Rep – volume: 86 start-page: 403 year: 1994 end-page: 408 ident: CR24 article-title: Bilateral optic neuritis with branch retinal artery occlusion associated with vaccination publication-title: Doc Ophthalmol – volume: 27 start-page: 517 year: 2019 end-page: 520 ident: CR61 article-title: Vaccine-associated uveitis publication-title: Ocul Immunol Inflamm – year: 2021 ident: CR56 article-title: Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine publication-title: Int Ophthalmol doi: 10.1007/s10792-021-01971-2 – volume: 63 start-page: 3502 year: 2011 end-page: 3511 ident: CR73 article-title: Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus publication-title: Arthritis Rheum – year: 2021 ident: CR51 article-title: Association of ocular adverse events with inactivated COVID-19 vaccination in patients in Abu Dhabi publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2021.3477 – volume: 20 start-page: 92 year: 2020 ident: CR68 article-title: Central retinal vein occlusion in a young healthy COVID-19 patient: a case report publication-title: Am J Ophthalmol Case Rep – volume: 78 start-page: 385 year: 2020 end-page: 386 ident: CR15 article-title: Bilateral trochlear nerve palsy due to cerebral vasculitis related to COVID-19 infection publication-title: Arq Neuropsiquiatr – volume: 138 start-page: 575 year: 2020 end-page: 578 ident: CR18 article-title: Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province publication-title: China JAMA Ophthalmol – volume: 108 start-page: 1097 year: 2001 end-page: 1104 ident: CR71 article-title: Mechanisms for the induction of autoimmunity by infectious agents publication-title: J Clin Invest – volume: 147 start-page: 739 year: 2021 end-page: 743 ident: CR37 article-title: Association of COVID-19 vaccination and facial nerve palsy: a case-control study publication-title: JAMA Otolaryngol Head Neck Surg – volume: 222 start-page: 446 year: 1996 end-page: 450 ident: CR3 article-title: Virus RNA persists within the retina in coronavirus-induced retinopathy publication-title: Virology – volume: 27 start-page: 100550 year: 2020 ident: CR11 article-title: Retinal findings in patients with COVID-19: results from the SERPICO-19 study publication-title: EClinicalMedicine – volume: 589 start-page: 16 year: 2021 end-page: 18 ident: CR31 article-title: The lightning-fast quest for COVID vaccines and what it means for other diseases publication-title: Nature – volume: 25 start-page: 137 year: 2021 ident: CR75 article-title: Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19 publication-title: Crit Care – year: 2021 ident: CR35 article-title: Post coronavirus disease (COVID-19) reactivation of a quiescent unilateral anterior uveitis publication-title: SN Compr Clin Med doi: 10.1080/02713683.2021.1905001 – volume: 173 start-page: 1027 year: 2020 end-page: 1028 ident: CR19 article-title: Myasthenia gravis associated with SARS-CoV-2 infection publication-title: Ann Intern Med – year: 2021 ident: CR41 article-title: Vogt-Koyanagi-harada disease associated with COVID-19 mRNA vaccine publication-title: Ocul Immunol Inflamm doi: 10.1080/09273948.2021.1974492 – year: 2021 ident: CR34 publication-title: Coronavirus (COVID-19) vaccine-induced immune thrombotic thrombocytopenia (VITT) – volume: 10 start-page: 201 year: 2021 end-page: 209 ident: CR20 article-title: Ophthalmological considerations for COVID-19 vaccination in patients with inflammatory eye diseases and autoimmune disorders publication-title: Ophthalmol Ther – volume: 105 start-page: 893 year: 2021 end-page: 896 ident: CR47 article-title: Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine publication-title: Br J Ophthalmol – volume: 28 start-page: 922 year: 2020 end-page: 925 ident: CR67 article-title: Panuveitis and optic neuritis as a possible initial presentation of the novel coronavirus disease 2019 (COVID-19) publication-title: Ocul Immunol Inflamm – volume: 19 start-page: 80 year: 2006 end-page: 94 ident: CR70 article-title: Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease publication-title: Clin Microbiol Rev – year: 2021 ident: CR43 article-title: Acute macular neuroretinopathy after COVID-19 vaccine publication-title: J Ophthalmic Inflamm Infection. doi: 10.21203/rs.3.rs-632137/v1 – volume: 20 start-page: 100917 year: 2020 ident: CR8 article-title: Episcleritis as a possible presenting sign of the novel coronavirus disease: a case report publication-title: Am J Ophthalmol Case Rep – volume: 213 start-page: 2527 year: 2016 end-page: 2538 ident: CR30 article-title: Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview publication-title: J Exp Med – year: 2021 ident: CR59 article-title: Two cases of graves' disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants publication-title: Thyroid doi: 10.1089/thy.2021.0142 – volume: 116 start-page: 2457 year: 2009 end-page: 62.e2 ident: CR62 article-title: Uveitis in a patient treated with Bacille-Calmette-Guérin: possible antigenic mimicry of mycobacterial and retinal antigens publication-title: Ophthalmology – year: 2021 ident: CR42 article-title: Acute uveitis following COVID-19 vaccination publication-title: Ocul Immunol Inflamm doi: 10.1080/09273948.2021.1962917 – year: 2021 ident: CR45 article-title: Acute macular neuroretinopathy following COVID-19 vaccination publication-title: Eye (London) doi: 10.1038/s41433-021-01610-1 – year: 2021 ident: CR58 article-title: acute thyroiditis and bilateral optic neuritis following SARS-CoV-2 vaccination with CoronaVac: a case report publication-title: Ocul Immunol Inflamm doi: 10.1080/09273948.2021.1961815 – volume: 10 start-page: 976 year: 2021 end-page: 986 ident: CR6 article-title: In the eye of the storm: SARS-CoV-2 infection and replication at the ocular surface? publication-title: Stem Cells Transl Med – volume: 93 start-page: 139 year: 2021 end-page: 140 ident: CR66 article-title: Bilateral anterior uveitis as a part of a multisystem inflammatory syndrome secondary to COVID-19 infection publication-title: J Med Virol – volume: 8 start-page: 2324709620976018 year: 2020 ident: CR12 article-title: COVID-19-induced acute bilateral optic neuritis publication-title: J Investig Med High Impact Case Rep – volume: 22 start-page: 3240 year: 2004 end-page: 3242 ident: CR23 article-title: The first rapid onset optic neuritis after measles-rubella vaccination: case report publication-title: Vaccine – year: 2021 ident: CR52 article-title: Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report publication-title: Inflamm Res doi: 10.1007/s00011-021-01476-9 – volume: 26 start-page: 1017 year: 2020 end-page: 1032 ident: CR5 article-title: Extrapulmonary manifestations of COVID-19 publication-title: Nat Med – volume: 325 start-page: 2448 year: 2021 end-page: 2456 ident: CR74 article-title: US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, march 2 to april 21, 2021 publication-title: JAMA – volume: 13 start-page: 513 year: 2020 ident: 415_CR10 publication-title: Int Med Case Rep J doi: 10.2147/IMCRJ.S260252 – volume: 21 start-page: 195 year: 2021 ident: 415_CR29 publication-title: Nat Rev Immunol doi: 10.1038/s41577-021-00526-x – volume: 100 start-page: 238 year: 2021 ident: 415_CR33 publication-title: Kidney Int doi: 10.1016/j.kint.2021.04.025 – volume: 69 start-page: 1953 year: 2021 ident: 415_CR49 publication-title: Indian J Ophthalmol doi: 10.4103/ijo.IJO_1028_21 – volume: 20 start-page: 100917 year: 2020 ident: 415_CR8 publication-title: Am J Ophthalmol Case Rep doi: 10.1016/j.ajoc.2020.100917 – volume: 98 start-page: e1056 year: 2020 ident: 415_CR9 publication-title: Acta Ophthalmol doi: 10.1111/aos.14484 – volume: 23 start-page: 5657 year: 2017 ident: 415_CR64 publication-title: Med Sci Monit doi: 10.12659/MSM.905183 – volume: 50 start-page: 85 year: 2020 ident: 415_CR22 publication-title: Trop Doct doi: 10.1177/0049475519872370 – year: 2021 ident: 415_CR42 publication-title: Ocul Immunol Inflamm doi: 10.1080/09273948.2021.1962917 – volume: 40 start-page: 1070 year: 2021 ident: 415_CR48 publication-title: Cornea doi: 10.1097/ICO.0000000000002761 – volume: 22 start-page: 3240 year: 2004 ident: 415_CR23 publication-title: Vaccine doi: 10.1016/j.vaccine.2004.02.044 – volume: 70 start-page: 977 year: 2021 ident: 415_CR32 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm7027e2 – year: 2021 ident: 415_CR35 publication-title: SN Compr Clin Med doi: 10.1080/02713683.2021.1905001 – year: 2021 ident: 415_CR53 publication-title: Ocul Immunol Inflamm doi: 10.1080/09273948.2021.1949478 – year: 2021 ident: 415_CR17 publication-title: Orbit doi: 10.1080/01676830.2020.1867193 – volume: 362 start-page: 1659 year: 2003 ident: 415_CR27 publication-title: Lancet doi: 10.1016/S0140-6736(03)14802-7 – year: 2021 ident: 415_CR43 publication-title: J Ophthalmic Inflamm Infection. doi: 10.21203/rs.3.rs-632137/v1 – volume: 2021 start-page: 1 year: 2019 ident: 415_CR44 publication-title: Ocul Immunol Inflamm – volume: 11 start-page: 2274 year: 2015 ident: 415_CR26 publication-title: Hum Vaccin Immunother doi: 10.1080/21645515.2015.1009337 – year: 2021 ident: 415_CR41 publication-title: Ocul Immunol Inflamm doi: 10.1080/09273948.2021.1974492 – volume: 272 start-page: 42 year: 2014 ident: 415_CR4 publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2014.05.002 – volume: 9 start-page: 435 year: 2021 ident: 415_CR28 publication-title: Vaccines (Basel) doi: 10.3390/vaccines9050435 – year: 2021 ident: 415_CR56 publication-title: Int Ophthalmol doi: 10.1007/s10792-021-01971-2 – volume: 28 start-page: 391 year: 2020 ident: 415_CR1 publication-title: Ocul Immunol Inflamm doi: 10.1080/09273948.2020.1738501 – year: 2021 ident: 415_CR45 publication-title: Eye (London) doi: 10.1038/s41433-021-01610-1 – volume: 108 start-page: 1097 year: 2001 ident: 415_CR71 publication-title: J Clin Invest doi: 10.1172/JCI200114235 – volume: 147 start-page: 739 year: 2021 ident: 415_CR37 publication-title: JAMA Otolaryngol Head Neck Surg doi: 10.1001/jamaoto.2021.1259 – volume: 20 year: 2020 ident: 415_CR7 publication-title: IDCases doi: 10.1016/j.idcr.2020.e00774 – year: 2021 ident: 415_CR52 publication-title: Inflamm Res doi: 10.1007/s00011-021-01476-9 – volume: 21 start-page: 450 year: 2021 ident: 415_CR36 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(21)00076-1 – volume: 222 start-page: 446 year: 1996 ident: 415_CR3 publication-title: Virology doi: 10.1006/viro.1996.0442 – volume-title: Coronavirus (COVID-19) vaccine-induced immune thrombotic thrombocytopenia (VITT) year: 2021 ident: 415_CR34 – volume: 27 start-page: 517 year: 2019 ident: 415_CR61 publication-title: Ocul Immunol Inflamm doi: 10.1080/09273948.2019.1626188 – volume: 63 start-page: 3502 year: 2011 ident: 415_CR73 publication-title: Arthritis Rheum doi: 10.1002/art.30576 – volume: 20 start-page: 92 year: 2020 ident: 415_CR68 publication-title: Am J Ophthalmol Case Rep – volume: 138 start-page: 575 year: 2020 ident: 415_CR18 publication-title: China JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2020.1291 – volume: 12 start-page: 53 year: 2000 ident: 415_CR72 publication-title: Curr Opin Rheumatol doi: 10.1097/00002281-200001000-00009 – year: 2021 ident: 415_CR57 publication-title: Ocul Immunol Inflamm doi: 10.1080/09273948.2021.1957123 – volume: 63 start-page: 79 year: 2016 ident: 415_CR21 publication-title: Clin Infect Dis doi: 10.1093/cid/ciw224 – volume: 193 start-page: 28 year: 2008 ident: 415_CR2 publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2007.09.032 – volume: 27 start-page: 100550 year: 2020 ident: 415_CR11 publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2020.100550 – volume: 589 start-page: 16 year: 2021 ident: 415_CR31 publication-title: Nature doi: 10.1038/d41586-020-03626-1 – volume: 40 start-page: 398 year: 2020 ident: 415_CR13 publication-title: J Neuroophthalmol doi: 10.1097/WNO.0000000000001049 – volume: 69 start-page: 2550 year: 2021 ident: 415_CR38 publication-title: Indian J Ophthalmol doi: 10.4103/ijo.IJO_1658_21 – volume: 10 start-page: 976 year: 2021 ident: 415_CR6 publication-title: Stem Cells Transl Med doi: 10.1002/sctm.20-0543 – volume: 213 start-page: 2527 year: 2016 ident: 415_CR30 publication-title: J Exp Med doi: 10.1084/jem.20161596 – year: 2021 ident: 415_CR50 publication-title: Eye (London) doi: 10.1038/s41433-021-01671-2 – volume: 23 start-page: 101136 year: 2021 ident: 415_CR55 publication-title: Am J Ophthalmol Case Rep doi: 10.1016/j.ajoc.2021.101136 – volume: 93 start-page: 139 year: 2021 ident: 415_CR66 publication-title: J Med Virol doi: 10.1002/jmv.26229 – year: 2021 ident: 415_CR51 publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2021.3477 – volume: 325 start-page: 2448 year: 2021 ident: 415_CR74 publication-title: JAMA doi: 10.1001/jama.2021.7517 – volume: 43 start-page: 2841 year: 2002 ident: 415_CR65 publication-title: Invest Ophthalmol Vis Sci – volume: 116 start-page: 2457 year: 2009 ident: 415_CR62 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2009.05.021 – volume: 40 start-page: 520 year: 2020 ident: 415_CR16 publication-title: J Neuroophthalmol doi: 10.1097/WNO.0000000000001146 – volume: 24 start-page: 101200 year: 2021 ident: 415_CR46 publication-title: Am J Ophthalmol Case Rep doi: 10.1016/j.ajoc.2021.101200 – volume: 11 start-page: 21 year: 2021 ident: 415_CR40 publication-title: J Ophthalmic Inflamm Infect doi: 10.1186/s12348-021-00251-5 – volume: 8 start-page: 232470962097601 year: 2020 ident: 415_CR12 publication-title: J Investig Med High Impact Case Rep doi: 10.1177/2324709620976018 – volume: 21 year: 2020 ident: 415_CR14 publication-title: Am J Case Rep doi: 10.12659/AJCR.925897 – year: 2021 ident: 415_CR54 publication-title: J Am Assoc Pediatr Ophthalmol Strabismus doi: 10.1016/j.jaapos.2021.05.003 – volume: 86 start-page: 403 year: 1994 ident: 415_CR24 publication-title: Doc Ophthalmol doi: 10.1007/BF01204599 – volume: 26 start-page: 1017 year: 2020 ident: 415_CR5 publication-title: Nat Med doi: 10.1038/s41591-020-0968-3 – volume: 78 start-page: 385 year: 2020 ident: 415_CR15 publication-title: Arq Neuropsiquiatr doi: 10.1590/0004-282x20200052 – volume: 173 start-page: 1027 year: 2020 ident: 415_CR19 publication-title: Ann Intern Med doi: 10.7326/L20-0845 – volume: 105 start-page: 893 year: 2021 ident: 415_CR47 publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2021-319338 – year: 2021 ident: 415_CR58 publication-title: Ocul Immunol Inflamm doi: 10.1080/09273948.2021.1961815 – volume: 19 start-page: 80 year: 2006 ident: 415_CR70 publication-title: Clin Microbiol Rev doi: 10.1128/CMR.19.1.80-94.2006 – volume: 28 start-page: 922 year: 2020 ident: 415_CR67 publication-title: Ocul Immunol Inflamm doi: 10.1080/09273948.2020.1792512 – volume: 397 start-page: e11 year: 2021 ident: 415_CR39 publication-title: Lancet doi: 10.1016/S0140-6736(21)00872-2 – volume: 10 start-page: 201 year: 2021 ident: 415_CR20 publication-title: Ophthalmol Ther doi: 10.1007/s40123-021-00338-1 – volume: 36 start-page: e16 year: 2020 ident: 415_CR25 publication-title: Ophthalmic Plast Reconstr Surg doi: 10.1097/IOP.0000000000001517 – volume: 34 start-page: 101412 year: 2020 ident: 415_CR60 publication-title: Best Pract Res Clin Endocrinol Metab doi: 10.1016/j.beem.2020.101412 – volume: 5 start-page: 265 year: 2021 ident: 415_CR69 publication-title: Mod Rheumatol Case Rep doi: 10.1080/24725625.2021.1893961 – year: 2021 ident: 415_CR59 publication-title: Thyroid doi: 10.1089/thy.2021.0142 – volume: 25 start-page: 137 year: 2021 ident: 415_CR75 publication-title: Crit Care doi: 10.1186/s13054-021-03572-y – volume: 45 start-page: 774 year: 2020 ident: 415_CR63 publication-title: Curr Eye Res doi: 10.1080/02713683.2019.1705491 |
SSID | ssj0001285944 |
Score | 2.423724 |
SecondaryResourceType | review_article |
Snippet | The COVID-19 pandemic has galvanized the global response towards the development of new vaccines based on novel technologies at an unprecedented pace. Since... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 81 |
SubjectTerms | Internal Medicine Medicine Medicine & Public Health Ophthalmology Review |
SummonAdditionalLinks | – databaseName: Springer Nature OA Free Journals dbid: C24 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwEA86QXwRv61fRPBNA02brIlvMjemMH3Qjb2VNklR0E7c9uB_7yVNC3Mi-NxLKHdJf3e9u98hdBFrxQqADULbISNMG0FETg1RhWRZnBVJ7mYDDh7a_SG7H_Oxbwqb1tXudUrSfambZjdm4Z_YkgJLEsUJX0VrHGJ3e647vseh-rMiuHRTXOE2xkREjPtumd-3WUSkJTdzuVryR8rUIVFvC216FxLfVDbfRium3EHrA58k30VtMD3ufhk8KTC4d_gJwur3a9x5HN3dEirxKFMg6CyCs1I7GRDfQ8Ne97nTJ348AlE8kTMC8MOKBNwnLopEyVhANKuEkDQHuxT2JsJ3OMrbKtKR5mEudRgpTgtYpakOVbyPWuWkNIcIm1BRHYdGMmEYBCAZgDgz4I2EBlBOmADRWkWp8tzhdoTFW9qwHju1pqDW1Kk15QG6bNZ8VMwZf0qf15pP4YDbrEVWmsl8mkaWED6UUSICdFBZotkvZtLyDcLqZMFGjYAlz158Ur6-OBJtAZESQHGArmprpv72Tv94zaP_iR-jjci2S7gq7xPUmn3OzSk4MbP8zJ3Zbzcx4t8 priority: 102 providerName: Springer Nature |
Title | The Eye of the Storm: COVID-19 Vaccination and the Eye |
URI | https://link.springer.com/article/10.1007/s40123-021-00415-5 https://www.ncbi.nlm.nih.gov/pubmed/34914035 https://www.proquest.com/docview/2610909278 https://pubmed.ncbi.nlm.nih.gov/PMC8675299 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dSxwxEB_0BOmLVG3rWT0i-NambLLJblIoIuc3XH3Qk3tbdpMsFq57ftxB_e87ye0unIr4kpedhDAz2d9MPn4DsB9bI0qEDcqSSFBhnaKqYI6aUos8zsu0CLUBB7-Ts6G4GMnREjTljmoFPr6a2vl6UsOH8Y9_908HuOB_tc_ghA8MqL9s4OmjJJXLsILIlPqFOqjD_fmei5I61HfFdRpTxYWs39G8PswiVr0IQF_eo3x2mBow6uQjrNXBJTmce8M6LLlqA1YH9fH5JiToFOT4yZFJSTDwI1eYcP_9SfqXN-dHlGlykxsUDLYieWWDDIp_guHJ8XX_jNaFE6iRqZ5SBCZRphhYSVWmRscK81yjlGYFWqz0axT_0LxIDLfcyqjQNuJGshJ7WWYjE3-GTjWp3BYQFxlm48hpoZzA1CRHeBcO45TIIf4p1wXWqCgzNau4L24xzlo-5KDWDNWaBbVmsgvf2j53c06NN6X3Gs1n6Pr-PCOv3GT2mHFPFR9pnqoufJlboh0vFtozEWLvdMFGrYCn1V78Uv25DfTaCnMoBOkufG-smTVu-cY0t98xza_wgfvXE-HS9w50pg8zt4sxzbTowXKfC98m_V7YF8D2dMR6wYH_A4WH7wE |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT8MwDLZ4SMAF8WY8g8QNIvpI2oQbGpvGY3AApt2iNkkFEnSIjQP_HifrJgYIiXOdqLKTfnZtfwY4jI1mBcIGDZOAUWasoCIPLdWFZFmcFWnuZwO2b5LWA7vs8m5Fk-N6Yb7l70_6zIE-dYUEjhqKUz4NswwjZVe-V0_qX_6nCC797Fa8gzEVEeNVj8zv20zi0A_n8meN5LdEqcef5hIsVo4jORtaehmmbLkCc-0qNb4KCRqcND4s6RUEnTpyh8H0yymp33YuzmkoSSfTKOjtQLLSeBkUX4OHZuO-3qLVUASqeSoHFEGHFSk6TVwUqZaxwBhWCyHDHK1RuPuHX98oT3RkIsODXJog0jwscJUJTaDjdZgpe6XdBGIDHZo4sJIJyzDsyBC6mUUfJLCIbcLWIBypSOmKMdwNrnhWY65jr1aFalVerYrX4Gi85nXIl_Gn9MFI8wqPtctVZKXtvfdV5GjgAxmlogYbQ0uM94uZdCyDuDqdsNFYwFFmTz4pnx49dbbA-AgBuAbHI2uq6s72_3jNrf-J78N86759ra4vbq62YSFyDRO-znsHZgZv73YX3ZhBvufP7ye_5OHw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZS8QwEB48QHwRb9czgm8a7JG0iW-yungreOBbaHOgoF3R9cF_7yTbLa6K4HMnocwk_WY6M98AbKVGM4ewQeMsYpQZK6goY0u1k6xIC5eXYTbg-UV2dMtO7vn9ly7-UO0-SEn2exo8S1PV230xbrdpfGPeFaC-vMATRnHKR2EcI5WQqG1n7S9_WQSXYaIr3syUioTxunPm922G0emHy_mzcvJb-jSgUmcapmp3kuz37T8DI7aahYnzOmE-BxkeA3L4YUnXEXT1yDWG2M97pH15d3xAY0nuCo2CwTqkqEyQQfF5uO0c3rSPaD0qgWqeyx5FKGIuR1eKC5drmQqMbLUQMi7RRs7fSvwmJ2WmE5MYHpXSRInmscNVJjaRThdgrOpWdgmIjXRs0shKJizDYKRAQGcWPZPIIuIJ24J4oCKlax5xP87iSTUMyEGtCtWqgloVb8F2s-alz6Lxp_TmQPMKD7vPYBSV7b6_qcSTw0cyyUULFvuWaPZLmfTcg7g6H7JRI-CJtIefVI8PgVBbYNSEsNyCnYE1VX2T3_54zeX_iW_AxNVBR50dX5yuwGTiuyhC8fcqjPVe3-0a-ja9cj0c30_uU-o3 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Eye+of+the+Storm%3A+COVID-19+Vaccination+and+the+Eye&rft.jtitle=Ophthalmology+and+therapy&rft.au=Ng%2C+Xin+Le&rft.au=Betzler%2C+Bjorn+Kaijun&rft.au=Ng%2C+Sean&rft.au=Chee%2C+Soon+Phaik&rft.date=2022-02-01&rft.issn=2193-8245&rft.volume=11&rft.issue=1&rft.spage=81&rft_id=info:doi/10.1007%2Fs40123-021-00415-5&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2193-8245&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2193-8245&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2193-8245&client=summon |